Thompson A - Search Results

1

Re-examining blood donor deferral criteria relating to injecting drug use.

Quinn B, Seed C, Keller A, Maher L, Wilson D, Farrell M, Caris S, Williams J, Madden A, Thompson A, Pink J, Hellard ME. Quinn B, et al. Among authors: thompson a. Int J Drug Policy. 2017 Oct;48:9-17. doi: 10.1016/j.drugpo.2017.05.058. Epub 2017 Jun 27. Int J Drug Policy. 2017. PMID: 28666205 Review.

2

Current and emerging antiviral treatments for hepatitis C infection.

Doyle JS, Aspinall E, Liew D, Thompson AJ, Hellard ME. Doyle JS, et al. Br J Clin Pharmacol. 2013 Apr;75(4):931-43. doi: 10.1111/j.1365-2125.2012.04419.x. Br J Clin Pharmacol. 2013. PMID: 22882367 Free PMC article. Review.

3

The role of viral and host genetics in natural history and treatment of chronic HCV infection.

Doyle JS, Hellard ME, Thompson AJ. Doyle JS, et al. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):413-27. doi: 10.1016/j.bpg.2012.09.004. Best Pract Res Clin Gastroenterol. 2012. PMID: 23199501 Review.

4

Eradication of hepatitis C infection: the importance of targeting people who inject drugs.

Hellard M, Doyle JS, Sacks-Davis R, Thompson AJ, McBryde E. Hellard M, et al. Hepatology. 2014 Feb;59(2):366-9. doi: 10.1002/hep.26623. Epub 2013 Dec 24. Hepatology. 2014. PMID: 23873507 Free PMC article. No abstract available.

5

Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia.

Scott N, Iser DM, Thompson AJ, Doyle JS, Hellard ME. Scott N, et al. J Gastroenterol Hepatol. 2016 Apr;31(4):872-82. doi: 10.1111/jgh.13223. J Gastroenterol Hepatol. 2016. PMID: 26514998

6

The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.

Wade AJ, Macdonald DM, Doyle JS, Gordon A, Roberts SK, Thompson AJ, Hellard ME. Wade AJ, et al. Among authors: thompson aj. PLoS One. 2015 Nov 12;10(11):e0142770. doi: 10.1371/journal.pone.0142770. eCollection 2015. PLoS One. 2015. PMID: 26562516 Free PMC article.

7

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies.

Martinello M, Hellard M, Shaw D, Petoumenos K, Applegate T, Grebely J, Yeung B, Maire L, Iser D, Lloyd A, Thompson A, Sasadeusz J, Haber P, Dore GJ, Matthews GV. Martinello M, et al. Among authors: thompson a. Antivir Ther. 2016;21(5):425-34. doi: 10.3851/IMP3035. Epub 2016 Feb 11. Antivir Ther. 2016. PMID: 26867206 Clinical Trial.

8

Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model.

Scott N, McBryde ES, Thompson A, Doyle JS, Hellard ME. Scott N, et al. Among authors: thompson a. Gut. 2017 Aug;66(8):1507-1515. doi: 10.1136/gutjnl-2016-311504. Epub 2016 Apr 12. Gut. 2017. PMID: 27196586

9

Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus Infection.

Chen Yi Mei SL, Burchell J, Skinner N, Millen R, Matthews G, Hellard M, Dore GJ, Desmond PV, Sundararajan V, Thompson AJ, Visvanathan K, Sasadeusz J. Chen Yi Mei SL, et al. J Infect Dis. 2016 Sep 1;214(5):739-47. doi: 10.1093/infdis/jiw235. Epub 2016 Jun 9. J Infect Dis. 2016. PMID: 27284092 Free PMC article.

10

Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.

Doyle JS, Grebely J, Spelman T, Alavi M, Matthews GV, Thompson AJ, Dore GJ, Hellard ME; ATAHC Study Group. Doyle JS, et al. PLoS One. 2016 Jun 29;11(6):e0150655. doi: 10.1371/journal.pone.0150655. eCollection 2016. PLoS One. 2016. PMID: 27355323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,735 results

Search Page